Merck
  • Home
  • Search Results
  • Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Nature biotechnology (1997-11-05)
R Zufferey, D Nagy, R J Mandel, L Naldini, D Trono
ABSTRACT

Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® pLKO.1-puro eGFP shRNA Control Plasmid DNA, shRNA sequence targeting eGFP
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Cytokines and Chemokines
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Kinases
Sigma-Aldrich
MISSION® pLKO.1-puro TurboGFP shRNA Control Plasmid DNA, shRNA sequence targeting tGFP
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Ion Channels
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Apoptosis Pathway
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Cytokine and Chemokine Receptors
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, G-Protein Coupled Receptors
Sigma-Aldrich
MISSION® shRNA Human Gene Family Set, Lentiviral Particles, Nuclear Hormone Receptors